Epidermal Growth Factor Receptor: Key to Selective Intracellular Delivery
A A Rosenkranz1,2, T A Slastnikova2
1Faculty of Biology, Lomonosov Moscow State University, Moscow, 119234, Russia. aar@igb.ac.ru.
Abstract:
Epidermal growth factor receptor (EGFR) is an integral surface protein mediating cellular response to a number of growth factors. Its overexpression and increased activation due to mutations is one of the most common traits of many types of cancer. Development and clinical use of the agents, which block EGFR activation, became a prime example of the personalized targeted medicine. However, despite the obvious success in this area, cancer cure remains unattainable in most cases. Because of that, as well as the result of the search for possible ways to overcome the difficulties of treatment, a huge number of new treatment methods relying on the use of EGFR overexpression and its changes to destroy cancer cells. Modern data on the structure, functioning, and intracellular transport of EGFR, its natural ligands, as well as signaling cascades triggered by the EGFR activation, peculiarities of the EGFR expression and activation in oncological disorders, as well as applied therapeutic approaches aimed at blocking EGFR signaling pathway are summarized and analyzed in this review. Approaches to the targeted delivery of various chemotherapeutic agents, radionuclides, immunotoxins, photosensitizers, as well as the prospects for gene therapy aimed at cancer cells with EGFR overexpression are reviewed in detail. It should be noted that increasing attention is being paid nowadays to the development of multifunctional systems, either carrying several different active agents, or possessing several environment-dependent transport functions. Potentials of the systems based on receptor-mediated endocytosis of EGFR and their possible advantages and limitations are discussed.
Insights
Epidermal growth factor receptor (EGFR) is crucial in cancer development. This review explores novel therapies targeting EGFR overexpression, including targeted delivery and gene therapy, to improve cancer treatment outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Epidermal growth factor receptor (EGFR) is a cell surface protein involved in growth factor signaling.
- EGFR overexpression and mutations are common in various cancers, driving tumor growth.
- Targeted therapies blocking EGFR activation represent a key advance in personalized medicine.
Purpose of the Study:
- To review current understanding of EGFR structure, function, and signaling in cancer.
- To analyze therapeutic strategies targeting EGFR overexpression and its signaling pathway.
- To discuss novel approaches for targeted drug delivery and gene therapy for EGFR-driven cancers.
Main Methods:
- Comprehensive literature review of EGFR biology and therapeutic interventions.
- Analysis of signaling cascades, intracellular transport, and expression patterns of EGFR.
- Evaluation of targeted delivery systems, including chemotherapeutics, radionuclides, immunotoxins, and photosensitizers.
Main Results:
- EGFR plays a significant role in multiple cancer types, making it a key therapeutic target.
- Various agents and strategies are being developed to block EGFR signaling and exploit its overexpression.
- Multifunctional systems and receptor-mediated endocytosis show promise for enhanced cancer cell targeting.
Conclusions:
- Despite successes, EGFR-targeted therapies face challenges, necessitating innovative treatment approaches.
- Targeted delivery systems and gene therapy offer potential for overcoming treatment resistance.
- Further research into multifunctional systems and EGFR-mediated endocytosis could lead to improved cancer therapies.
More Related Videos
Related Concept Videos
Mitogens and the Cell Cycle
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Intracellular Signaling Affects Focal Adhesions
Some...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:


